Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
pegfilgrastim 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pegfilgrastim (substance) |
Inferred relationship |
Some |
|
Product containing pegfilgrastim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pegfilgrastim (substance) |
Inferred relationship |
Some |
1 |
pegfilgrastim 6 mg/0,6 ml injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pegfilgrastim (substance) |
Inferred relationship |
Some |
|
pegfilgrastim 6 mg/0,6 ml injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pegfilgrastim (substance) |
Inferred relationship |
Some |
|
Product containing precisely filgrastim (as pegfilgrastim) 6 milligram/0.6 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Pegfilgrastim (substance) |
Inferred relationship |
Some |
1 |
Product containing pegfilgrastim in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pegfilgrastim (substance) |
Inferred relationship |
Some |
1 |
Product containing only pegfilgrastim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pegfilgrastim (substance) |
Inferred relationship |
Some |
1 |
Pegfilgrastim only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pegfilgrastim (substance) |
Inferred relationship |
Some |
1 |
Filgrastim (as pegfilgrastim) 10 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pegfilgrastim (substance) |
Inferred relationship |
Some |
1 |